Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-14004572Phase 4Completed
Phase 4, randomised, double-blind trial of norepinephrine in hypotension (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Median absolute performance error of systolic blood pressure control. Started May 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-14004572.